Fundz

Mitokinin, Inc. reported raising $4.53 Million in an initial SEC Form D filing, from an offering of $4.53 Million

PRIVATESep 18, 2017

Amount Raised

$4.53 Million

$4.53 Million sold, per SEC Form D (first sale Sep 18, 2017)

Round Type

Seed

New YorkBiotechnology

Quick answer

Mitokinin, Inc. raised $4.53 Million in a Seed round, dated September 18, 2017. Mitokinin, Inc. is based in New York, New York, United States.

How much did Mitokinin, Inc. raise?
Mitokinin, Inc. raised $4.53 Million in a Seed round on September 18, 2017.
What does Mitokinin, Inc. do?
Leveraging Endogenous Repair Mechanisms to Drive Disease Modification in Parkinson’s Disease and Huntington’s Disease
Where is Mitokinin, Inc. based and how big is it?
Mitokinin, Inc. is based in New York, New York, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Mitokinin, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Windtree Therapeutics raised $10M on November 2, 2017.
  • Breathe Technologies, Inc. raised $6.3M on November 2, 2017.
  • TELA Bio raised $15M on November 2, 2017.
  • valisure llc raised $170K (Pre-Seed) on November 2, 2017.
  • MicroOptx, Inc. raised $1.4M (Seed) on November 2, 2017.
  • ONCOSEC MEDICAL Inc raised $4.9M (Seed) on November 2, 2017.

Who to call at Mitokinin, Inc., and when

A new round usually means Mitokinin, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Mitokinin, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mitokinin, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mitokinin, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mitokinin, Inc.

Location

45 BROADWAY, SUITE 1440

New York, New York, United States

About

Leveraging Endogenous Repair Mechanisms to Drive Disease Modification in Parkinson’s Disease and Huntington’s Disease

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mitokinin, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Mitokinin, Inc.'s next move

See what Strategic adds

Mitokinin, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.